The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 4,006,119 | 221,700 | SH | SOLE | 221,700 | 0 | 0 | |||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,197,150 | 217,000 | SH | SOLE | 217,000 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 86,915,534 | 4,158,638 | SH | SOLE | 4,158,638 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,540,650 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | |||
| BIOHAVEN LTD | COM | G1110E107 | 12,916,800 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | |||
| BLACK DIAMOND THERAPEUTICS | COM | 09203E105 | 1,388,750 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||
| CODEXIS INC | COM | 192005106 | 1,890,000 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 15,226,900 | 845,000 | SH | SOLE | 845,000 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,205,365 | 566,700 | SH | SOLE | 566,700 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 4,240,600 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| EDAP TMS S A | SPONSORED ADR | 268311107 | 3,503,600 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 6,316,250 | 815,000 | SH | SOLE | 815,000 | 0 | 0 | |||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 7,974,650 | 2,285,000 | SH | SOLE | 2,285,000 | 0 | 0 | |||
| FORTRESS BIOTECH INC | COM | 34960Q109 | 1,820,500 | 3,310,000 | SH | SOLE | 3,310,000 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 473,880 | 143,600 | SH | SOLE | 143,600 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 7,543,500 | 2,350,000 | SH | SOLE | 2,350,000 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 4,044,000 | 3,370,000 | SH | SOLE | 3,370,000 | 0 | 0 | |||
| HARROW HEALTH INC | COM | 415858109 | 71,876,000 | 3,775,000 | SH | SOLE | 3,775,000 | 0 | 0 | |||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 9,752,500 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | |||
| IGM BIOSCIIENCES INC | COM | 449585108 | 586,105 | 63,500 | SH | SOLE | 63,500 | 0 | 0 | |||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 4,893,600 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,963,840 | 421,000 | SH | SOLE | 421,000 | 0 | 0 | |||
| JASPER | COM | 481116101 | 917,823 | 669,944 | SH | SOLE | 669,944 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 6,480,000 | 720,000 | SH | SOLE | 720,000 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 3,195,150 | 1,785,000 | SH | SOLE | 1,785,000 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COM | 492327101 | 14,169,477 | 352,650 | SH | SOLE | 352,650 | 0 | 0 | |||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 242,050 | 98,796 | SH | SOLE | 98,796 | 0 | 0 | |||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 4,350,700 | 1,390,000 | SH | SOLE | 1,390,000 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 4,479,995 | 570,700 | SH | SOLE | 570,700 | 0 | 0 | |||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 6,787,500 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | |||
| MORPHOSYS AG | SPONSORED ADS | 617760202 | 9,034,069 | 1,209,380 | SH | SOLE | 1,209,380 | 0 | 0 | |||
| NYXOAH S A | SHS | B6S7WD106 | 3,564,450 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 29,824,800 | 5,780,000 | SH | SOLE | 5,780,000 | 0 | 0 | |||
| PROQR THERAPEUTICS NV | SHS EURO | N71542109 | 1,057,860 | 653,000 | SH | SOLE | 653,000 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 6,435,300 | 2,692,594 | SH | SOLE | 2,692,594 | 0 | 0 | |||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 12,120,150 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | |||
| SPECTRUM PHARMACEUTICALS | COM NEW | 85916J409 | 2,951,995 | 3,074,995 | SH | SOLE | 3,074,995 | 0 | 0 | |||
| SUTRO BIOPHARMA INC | COM | 869367102 | 1,427,550 | 307,000 | SH | SOLE | 307,000 | 0 | 0 | |||
| TELA BIO INC | COM | 872381108 | 16,005,400 | 1,580,000 | SH | SOLE | 1,580,000 | 0 | 0 | |||
| THERAVANCE BIOPHARMA INC | COM | G8807B106 | 5,625,225 | 543,500 | SH | SOLE | 543,500 | 0 | 0 | |||
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 5,574,675 | 597,500 | SH | SOLE | 597,500 | 0 | 0 | |||
| TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 1,386,472 | 4,764,508 | SH | SOLE | 4,764,508 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 4,066,585 | 1,701,500 | SH | SOLE | 1,701,500 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 5,899,500 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 8,839,380 | 177,000 | SH | SOLE | 177,000 | 0 | 0 | |||
| VERASTEM INC | COM NEW | 92337C203 | 758,880 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | |||
| XOMA CORP DEL | COM NEW | 98419J206 | 594,750 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||